Try our corporate solution for free!
(212) 419-8286

Sanofi - revenue by segment 2014-2019

In 2019, the French pharmaceutical and healthcare company by the name of Sanofi generated approximately 25.7 billion U.S. dollars through its pharmaceuticals segment. Sanofi’s relatively new consumer healthcare segment earned the company about 4.7 billion U.S. dollars in that year.

Sanofi’s top products

Sanofi develops various pharmaceutical products, including Aubagio, Lovenox, and Dupixent. In 2018 as well as 2019, the company’s top product based on revenue was Lantus. In 2019, this long-acting insulin used to treat diabetes, generated some three billion U.S. dollars. Aubagio earned the company roughly 1.89 billion U.S. dollars within the same year.

Top U.S. drugs

Based on sales numbers, Humira was by far the top prescription drug in the United States in 2018. The drug generated over 18 billion U.S. dollars in the United States that year, while Enbrel, which stood in second place, reached about 8 billion U.S. dollars. The country’s most prescribed medicines, however, were Atorvastatin, Lisinopril, and Levothyroxine. One hundred fourteen million prescriptions for Atorvastatin were dispensed in 2018.

Revenue of Sanofi by segment from 2014 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

March 2020



Survey time period

2014 to 2019

Supplementary notes

* During 2016, the Animal Health and the Consumer Healthcare segments were the objects of a swap deal between Sanofi and Boehringer Ingelheim. Since 2016, Animal Health revenues were no longer part of Sanofi's total revenues.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Sanofi"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.